Literature DB >> 23937331

L-asparaginase with methotrexate and dexamethasone is an effective treatment combination in blastic plasmacytoid dendritic cell neoplasm.

Bérengère Gruson1, Ioana Vaida, Lavinia Merlusca, Amandine Charbonnier, Anne Parcelier, Gandhi Damaj, Bruno Royer, Jean-Pierre Marolleau.   

Abstract

Entities:  

Keywords:  L-asparaginase; blastic plasmacytoid dendritic cell neoplasm; methotrexate; plasmacytoid dendritic cell

Mesh：

Substances：

Year:  2013        PMID： 23937331     DOI： 10.1111/bjh.12523

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  8 in total

Review 1.  Blastic Plasmacytoid Dendritic Cell Neoplasm.

Authors:  Daniel Kerr; Ling Zhang; Lubomir Sokol
Journal:  Curr Treat Options Oncol       Date:  2019-02-04

2.  Blastic plasmacytoid dendritic cell neoplasm: skin and bone marrow infiltration of three cases and the review of the literature.

Authors:  Figen Atalay; Gülşen Tükenmez Demirci; Dilek Bayramgürler; Elif Birtaş Ateşoğlu; Semsi Yıldız
Journal:  Indian J Hematol Blood Transfus       Date:  2014-10-14       Impact factor: 0.900

3.  In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent.

Authors:  Fanny Angelot-Delettre; Anne Roggy; Arthur E Frankel; Baptiste Lamarthee; Estelle Seilles; Sabeha Biichle; Bernard Royer; Eric Deconinck; Eric K Rowinsky; Christopher Brooks; Valerie Bardet; Blandine Benet; Hind Bennani; Zehaira Benseddik; Agathe Debliquis; Daniel Lusina; Mikael Roussel; Françoise Solly; Michel Ticchioni; Philippe Saas; Francine Garnache-Ottou
Journal:  Haematologica       Date:  2014-11-07       Impact factor: 9.941

4.  BPDCN: When polychemotherapy does not compromise allogeneic CD123 CAR-T cell cytotoxicity.

Authors:  Margaux Poussard; Laure Philippe; Maxime Fredon; Elodie Bôle-Richard; Sabeha Biichle; Florian Renosi; Sophie Perrin; Marie Kroemer; Samuel Limat; Francis Bonnefoy; Etienne Daguindau; Eric Deconinck; Bérengère Gruson; Philippe Saas; Olivier Adotévi; Francine Garnache-Ottou; Fanny Angelot-Delettre
Journal:  EJHaem       Date:  2020-12-13

5.  Blastic plasmacytoid dendritic cell neoplasm in children: A review of two cases.

Authors:  Wenjun Deng; Minghua Yang; Feimei Kuang; Yingting Liu; Hui Zhang; Lizhi Cao; Min Xie; Liangchun Yang
Journal:  Mol Clin Oncol       Date:  2017-08-08

6.  Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients.

Authors:  Kamel Laribi; Alix Baugier de Materre; Mohamad Sobh; Lorenzo Cerroni; Caterina Giovanna Valentini; Tomohiro Aoki; Ritsuro Suzuki; Kengo Takeuchi; Arthur E Frankel; Carlo Cota; David Ghez; Ronan Le Calloch; Livio Pagano; Tony Petrella
Journal:  Blood Adv       Date:  2020-10-13

7.  Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm.

Authors:  Laure Philippe; Adam Ceroi; Elodie Bôle-Richard; Alizée Jenvrin; Sabeha Biichle; Sophie Perrin; Samuel Limat; Francis Bonnefoy; Eric Deconinck; Philippe Saas; Francine Garnache-Ottou; Fanny Angelot-Delettre
Journal:  Haematologica       Date:  2017-08-10       Impact factor: 9.941

Review 8.  Conventional Therapeutics in BPDCN Patients-Do They Still Have a Place in the Era of Targeted Therapies?

Authors:  Margaux Poussard; Fanny Angelot-Delettre; Eric Deconinck
Journal:  Cancers (Basel)       Date:  2022-08-02       Impact factor: 6.575
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.